Clinical Trial Update: Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation and Pain [Phase 3]

View source ↗

Summary

Phase 3 trial update on KPI-121 for post-surgical ocular inflammation and pain shows safety and efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-surgical Ocular Pain
• Postoperative Ocular Inflammation

Drugs mentioned

• KPI-121

Snippet

Sponsor: Kala Pharmaceuticals, Inc. | Conditions: Post Surgical Ocular Inflammation and Pain | Phase 3 | Status: COMPLETED | Results posted: 2019-04-17